title: Age-Related Macular Degeneration: Genetics and Biology.
abstract: Age-related macular degeneration (AMD), widely prevalent across the globe, is a major stakeholder among adult visual morbidity and blindness, not only in the Western world but also in Asia. Several risk factors have been identified, including critical genetic factors, which were never imagined 2 decades ago. The etiopathogenesis is emerging to demonstrate that immune and complement-related inflammation pathway members chronically exposed to environmental insults could justifiably influence disease morbidity and treatment outcomes. Approximately half a dozen physiological and biochemical cascades are disrupted in the AMD disease genesis, eventually leading to the distortion and disruption of the subretinal space, subretinal pigment epithelium, and Bruch membrane, thus setting off chaos and disorder for signs and symptoms to manifest. Approximately 3 dozen genetic factors have so far been identified, including the recent ones, through powerful genomic technologies and large robust sample sizes. The noteworthy genetic variants (common and rare) are complement factor H, complement factor H-related genes 1 to 5, C3, C9, ARMS2/HTRA1, vascular endothelial growth factor A, vascular endothelial growth factor receptor 2/KDR, and rare variants (show causal link) such as TIMP3, fibrillin, COL4A3, MMP19, and MMP9. Despite the enormous amount of scientific information generated over the years, diagnostic genetic or biomarker tests are still not available for clinicians to understand the natural course of the disease and its management in a patient. However, further research in the field should reduce this gap not only by aiding the clinician but also through the possibilities of clinical intervention with complement pathway-related inhibitors entering preclinical and clinical trials in the near future.
authors.affiliation: From Narayana Nethralaya, Narayana Health City, Bangalore, India.
authors.forename: Govindasamy
authors.initials: G
authors.lastname: Kumaramanickavel
mesh_terms: D003165:Complement System Proteins / Q000235:genetics / Q000276:immunology; D005109:Extracellular Matrix / Q000502:physiology; D005136:Eye Proteins / Q000235:genetics; D020022:Genetic Predisposition to Disease; D006801:Humans; D050356:Lipid Metabolism; D008268:Macular Degeneration / Q000209:etiology / Q000235:genetics / Q000276:immunology / Q000503:physiopathology; D012307:Risk Factors; D042461:Vascular Endothelial Growth Factor A / Q000502:physiology
chemical_list: D005136:Eye Proteins; D042461:Vascular Endothelial Growth Factor A; D003165:Complement System Proteins